secwatch.observer — SEC 8-K summary
======================================

Issuer:     Orgenesis Inc. (—)
CIK:        0001460602
Form:       8-K
Filed at:   2026-06-02T21:26:42+00:00
Accession:  0001493152-26-026914
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 5.03, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Orgenesis shareholders approve 10x increase in authorized shares to 150M and convertible loan deal
--------------------------------------------------------------------------------

- Shareholders approved amendment to increase authorized common shares from 14,583,333 to 150,000,000.
- Vote: 5,153,345 for, 61,005 against, 1,201,381 abstentions on the amendment.
- Approved Convertible Loan Agreement with Theracell Laboratories IKE and Alpha Prosperity Fund SPC for potential share issuance.
- Ratified appointment of Kesselman & Kesselman (PwC) as auditor for FY 2025; votes: 6,400,038 for, 14,552 against.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1460602/000149315226026914/0001493152-26-026914-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1460602/000149315226026914/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-026914

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer